Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002874 (
aplastic anemia
)
5,905
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Idiopathic pneumonia syndrome
(
IPS
) is a critical complication following allogeneic hematopoietic SCT (HSCT); however, few reports have analyzed the risk factors for
IPS
in children. A total of 210 consecutive pediatric patients, including 131 boys and 79 girls, with various hematologic malignancies,
aplastic anemia
or solid tumors who underwent allogeneic HSCT were analyzed to clarify the incidence and risk factors for
IPS
. Patient and transplantation characteristics after allogeneic HSCT were compared between patients with and without
IPS
. Cumulative incidence rates of
IPS
120 days after allogeneic HSCT were 6.7% (14/210). Of 14 patients with
IPS
, 11 (78.6%) died after developing
IPS
. The presence of prior HSCT was more frequent in patients with
IPS
(
IPS
group) than in those without
IPS
(non-
IPS
group; 35.7 vs 12.8%, respectively, P=0.018). The
IPS
group contained more patients with acute GVHD (grade II-IV) than the non-
IPS
group (50.0 vs 18.9%, respectively, P=0.006). The association of these two factors with
IPS
was further confirmed by multivariate analysis. We should be aware of these risk factors in patients who have undergone allogeneic HSCT.
...
PMID:Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children. 2395 35